"These Drugs Could Cut American Health Costs by $250 Billion (If Only We Could Take Them)" July 20, 2016 Dmitry Karshtedt is quoted by MarketWatch about patent litigation related to biosimilar drugs. Read more at: http://www.marketwatch.com/story/these-new-drugs-might-never-get-a-chance-to-sa…